• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Phibro Animal Health Corporation Declares Quarterly Dividend

    5/6/25 4:15:00 PM ET
    $PAHC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $PAHC alert in real time by email

    The Board of Directors of Phibro Animal Health Corporation (NASDAQ:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 25, 2025, to stockholders of record at the close of business on June 4, 2025.

    About Phibro Animal Health Corporation

    Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit www.pahc.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250506093609/en/

    Phibro Animal Health Corporation

    Glenn David

    Chief Financial Officer

    +1-201-329-7300

    Or

    [email protected]

    Get the next $PAHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PAHC

    DatePrice TargetRatingAnalyst
    9/10/2024$22.00Neutral
    JP Morgan
    12/7/2023$9.00Underperform
    Exane BNP Paribas
    12/21/2022$18.00Buy
    ROTH Capital
    7/25/2022$22.00Equal Weight → Underweight
    Barclays
    1/10/2022$23.00Underweight → Equal-Weight
    Barclays
    11/18/2021$23.00Equal-Weight
    Morgan Stanley
    8/5/2021$25.00Neutral
    Credit Suisse
    7/7/2021$23.00Equal-Weight → Underweight
    Barclays
    More analyst ratings

    $PAHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Phibro Animal Health Corporation

      SC 13D/A - PHIBRO ANIMAL HEALTH CORP (0001069899) (Subject)

      11/15/24 4:15:40 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Phibro Animal Health Corporation

      SC 13G/A - PHIBRO ANIMAL HEALTH CORP (0001069899) (Subject)

      11/14/24 12:51:31 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Phibro Animal Health Corporation

      SC 13G/A - PHIBRO ANIMAL HEALTH CORP (0001069899) (Subject)

      11/12/24 4:55:22 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PAHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Corcoran E Thomas bought $110,500 worth of shares (5,000 units at $22.10), increasing direct ownership by 20% to 30,000 units (SEC Form 4)

      4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)

      2/26/25 4:15:17 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Corcoran E Thomas bought $100,100 worth of shares (5,000 units at $20.02), increasing direct ownership by 25% to 25,000 units (SEC Form 4)

      4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)

      9/6/24 4:34:30 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PAHC
    Financials

    Live finance-specific insights

    See more
    • Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance

      Phibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its third quarter ended March 31, 2025, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended March 31, 2025 (compared to the three months ended March 31, 2024) Net sales of $347.8 million, an increase of $84.6 million, or 32% Net income of $20.9 million, an increase of $12.5 million Diluted earnings per share of $0.51, an increase of $0.30 Adjusted EBITDA of $54.9 million, an increase of $25.2 million, or 85% Adjusted net income of $25.7 million, an increase of $13.0 million Adjusted diluted EPS of $0.63, an incr

      5/7/25 4:30:00 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Phibro Animal Health Corporation Declares Quarterly Dividend

      The Board of Directors of Phibro Animal Health Corporation (NASDAQ:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 25, 2025, to stockholders of record at the close of business on June 4, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit www.p

      5/6/25 4:15:00 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

      Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its third quarter financial results on Wednesday, May 7, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 8, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the we

      4/23/25 4:00:00 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PAHC
    Leadership Updates

    Live Leadership Updates

    See more
    • Phibro Animal Health Corporation Announces the Appointment of Joyce J. Lee to Its Board of Directors

      The Board of Directors of Phibro Animal Health Corporation (NASDAQ:PAHC) today announced the appointment of Joyce J. Lee, MBA, as a Class II director of the Company, effective immediately. Ms. Lee will be an independent director. Her appointment fills a current vacancy and increases Board membership to nine directors, 6 of whom are independent directors. Ms. Lee brings a wealth of expertise and leadership to our Board of Directors, most recently serving as President of Cobb Vantress LLC, a premier genetics company dedicated to feeding the world through responsible genetic innovation. Before joining Cobb Vantress, Ms. Lee held executive positions at Elanco, Bayer Animal Health, and Zoetis.

      1/23/25 4:45:00 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • TerraCycle Appoints New Chief Financial Officer to Global Leadership Team

      Damian Finio to Succeed Javier Daly as Chief Financial Officer TRENTON, N.J., Sept. 6, 2023 /PRNewswire/ --­ TerraCycle Inc., the international leader in innovative sustainability solutions, today announced Damian Finio will join the company's global leadership team as Chief Financial Officer, effective October 2. Finio most recently served as Chief Financial Officer of Phibro Animal Health Corporation (NASDAQ:PAHC) and joins TerraCycle with more than 30 years of financial management experience, primarily in the life sciences industry having spent nearly half of his career at

      9/6/23 12:20:00 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Phibro Animal Health Corporation Announces the Appointment of Alejandro Bernal to Its Board of Directors and Declares Quarterly Dividend

      The Board of Directors of Phibro Animal Health Corporation (NASDAQ:PAHC) today announced the appointment of Alejandro Bernal, DVM, MS, MBA, as a Class III director of the Company, effective immediately. Mr. Bernal will be an independent director. His appointment fills a current vacancy and increases Board membership to nine directors, 6 of whom are independent directors. Mr. Bernal recently became Chief Executive Officer of PetDx® – The Liquid Biopsy Company for Pets™, a company based in San Diego, CA, and focused on early detection of cancer using Next Generation Sequencing (NGS) technology. Prior to joining PetDx, Mr. Bernal was the President for Mars Veterinary Health International and

      2/6/23 4:15:00 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PAHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Corcoran E Thomas bought $110,500 worth of shares (5,000 units at $22.10), increasing direct ownership by 20% to 30,000 units (SEC Form 4)

      4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)

      2/26/25 4:15:17 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Financial Officer David Glenn converted options into 30,000 shares (SEC Form 4)

      4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)

      2/11/25 4:15:14 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 3 filed by new insider Lee Joyce J.

      3 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)

      1/28/25 4:15:16 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PAHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • JP Morgan initiated coverage on Phibro Animal Health with a new price target

      JP Morgan initiated coverage of Phibro Animal Health with a rating of Neutral and set a new price target of $22.00

      9/10/24 7:55:45 AM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Exane BNP Paribas initiated coverage on Phibro Animal Health with a new price target

      Exane BNP Paribas initiated coverage of Phibro Animal Health with a rating of Underperform and set a new price target of $9.00

      12/7/23 6:24:15 AM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • ROTH Capital initiated coverage on Phibro Animal Health with a new price target

      ROTH Capital initiated coverage of Phibro Animal Health with a rating of Buy and set a new price target of $18.00

      12/21/22 7:33:06 AM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PAHC
    SEC Filings

    See more
    • Phibro Animal Health Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - PHIBRO ANIMAL HEALTH CORP (0001069899) (Filer)

      5/7/25 4:39:20 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by Phibro Animal Health Corporation

      10-Q - PHIBRO ANIMAL HEALTH CORP (0001069899) (Filer)

      5/7/25 4:16:44 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Phibro Animal Health Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - PHIBRO ANIMAL HEALTH CORP (0001069899) (Filer)

      5/6/25 4:20:27 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PAHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance

      Phibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its third quarter ended March 31, 2025, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended March 31, 2025 (compared to the three months ended March 31, 2024) Net sales of $347.8 million, an increase of $84.6 million, or 32% Net income of $20.9 million, an increase of $12.5 million Diluted earnings per share of $0.51, an increase of $0.30 Adjusted EBITDA of $54.9 million, an increase of $25.2 million, or 85% Adjusted net income of $25.7 million, an increase of $13.0 million Adjusted diluted EPS of $0.63, an incr

      5/7/25 4:30:00 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Phibro Animal Health Corporation Declares Quarterly Dividend

      The Board of Directors of Phibro Animal Health Corporation (NASDAQ:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 25, 2025, to stockholders of record at the close of business on June 4, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit www.p

      5/6/25 4:15:00 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

      Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its third quarter financial results on Wednesday, May 7, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 8, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the we

      4/23/25 4:00:00 PM ET
      $PAHC
      Biotechnology: Pharmaceutical Preparations
      Health Care